Status:
COMPLETED
Role of Leucine in the Regulation of Human Myofibrillar Protein Synthesis at Rest and Following Resistance Exercise
Lead Sponsor:
McMaster University
Collaborating Sponsors:
University of California, Davis
Canadian Institutes of Health Research (CIHR)
Conditions:
Regulation of Muscle Protein Synthesis
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
Muscle mass is normally maintained through the regulated balance between the processes of protein synthesis (i.e. making new muscle proteins) and protein breakdown (breaking down old muscle proteins)....
Eligibility Criteria
Inclusion
- male
- 18-35 years of age
- non-smoker/ non-tobacco product user
Exclusion
- heart disease
- vascular disease
- rheumatoid arthritis
- diabetes
- poor lung function
- uncontrolled blood pressure
- dizziness
- thyroid problems
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01492010
Start Date
June 1 2010
End Date
September 1 2010
Last Update
February 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Exercise Metabolism Research Laboratory, McMaster Univeristy
Hamilton, Ontario, Canada, L8S 4K1